These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19090047)

  • 1. Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.
    Cook J; Jeuland M; Maskery B; Lauria D; Sur D; Clemens J; Whittington D
    J Policy Anal Manage; 2009; 28(1):6-28. PubMed ID: 19090047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
    Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
    Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
    Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
    Mogasale V; Ramani E; Wee H; Kim JH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical Modeling of Endemic Cholera Transmission.
    Chao DL
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S738-S741. PubMed ID: 34550373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for oral cholera vaccines in urban Bangladesh.
    Sarker AR; Islam Z; Sultana M; Sheikh N; Mahumud RA; Islam MT; Meer RV; Morton A; Khan AI; Clemens JD; Qadri F; Khan JAM
    PLoS One; 2020; 15(4):e0232600. PubMed ID: 32353086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Private demand for cholera vaccines in Hue, Vietnam.
    Kim D; Canh DG; Poulos C; Thoa LT; Cook J; Hoa NT; Nyamete A; Thuy DT; Deen J; Clemens J; Thiem VD; Anh DD; Whittington D
    Value Health; 2008; 11(1):119-28. PubMed ID: 18237366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global economic evaluation of oral cholera vaccine: A systematic review.
    Teoh SL; Kotirum S; Hutubessy RCW; Chaiyakunapruk N
    Hum Vaccin Immunother; 2018 Feb; 14(2):420-429. PubMed ID: 29099647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi.
    Ilboudo PG; Le Gargasson JB
    BMC Infect Dis; 2017 Dec; 17(1):779. PubMed ID: 29258447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations around the introduction of a cholera vaccine in Bangladesh.
    Nelson CB; Mogasale V; Bari TI; Clemens JD
    Vaccine; 2014 Dec; 32(52):7033-6. PubMed ID: 24856784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera.
    Ali M; Kim DR; Kanungo S; Sur D; Manna B; Digilio L; Dutta S; Marks F; Bhattacharya SK; Clemens J
    Int J Infect Dis; 2018 Jan; 66():90-95. PubMed ID: 29174695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
    Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
    Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Private demand for cholera vaccines in Beira, Mozambique.
    Lucas ME; Jeuland M; Deen J; Lazaro N; MacMahon M; Nyamete A; Barreto A; von Seidlein L; Cumbane A; Songane FF; Whittington D
    Vaccine; 2007 Mar; 25(14):2599-609. PubMed ID: 17258844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience.
    Kim SY; Choi Y; Mason PR; Rusakaniko S; Goldie SJ
    S Afr Med J; 2011 Sep; 101(9):659-64. PubMed ID: 21920160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private demand for cholera vaccines in rural Matlab, Bangladesh.
    Islam Z; Maskery B; Nyamete A; Horowitz MS; Yunus M; Whittington D
    Health Policy; 2008 Feb; 85(2):184-95. PubMed ID: 17822799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
    Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
    Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Evaluation of a Government-Conducted Oral Cholera Vaccination Campaign-Haiti, 2013.
    Routh JA; Sreenivasan N; Adhikari BB; Andrecy LL; Bernateau M; Abimbola T; Njau J; Jackson E; Juin S; Francois J; Tohme RA; Meltzer MI; Katz MA; Mintz ED
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):37-42. PubMed ID: 29064362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
    Cookson ST; Stamboulian D; Demonte J; Quero L; Martinez de Arquiza C; Aleman A; Lepetic A; Levine MM
    Int J Epidemiol; 1997 Feb; 26(1):212-9. PubMed ID: 9126522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.